AQR Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,079
| Closed | -$128K | – | 2764 |
|
|
2024
Q2 | $128K | Sell |
15,079
-89,940
| -86% | -$764K | ﹤0.01% | 2474 |
|
|
2024
Q1 | $1.82M | Sell |
105,019
-12,273
| -10% | -$213K | ﹤0.01% | 1458 |
|
|
2023
Q4 | $1.5M | Buy |
117,292
+83,514
| +247% | +$1.07M | ﹤0.01% | 1460 |
|
|
2023
Q3 | $1.25M | Buy |
33,778
+27,087
| +405% | +$1M | ﹤0.01% | 1522 |
|
|
2023
Q2 | $269K | Buy |
6,691
+4,652
| +228% | +$187K | ﹤0.01% | 1980 |
|
|
2023
Q1 | $148K | Sell |
2,039
-3,389
| -62% | -$246K | ﹤0.01% | 2091 |
|
|
2022
Q4 | $445K | Sell |
5,428
-14,979
| -73% | -$1.23M | ﹤0.01% | 1852 |
|
|
2022
Q3 | $1.93M | Buy |
+20,407
| New | +$1.93M | ﹤0.01% | 1218 |
|
|
2022
Q2 | – | Sell |
-1,336
| Closed | -$310K | – | 2183 |
|
|
2022
Q1 | $310K | Buy |
+1,336
| New | +$310K | ﹤0.01% | 1956 |
|
|
2021
Q3 | – | Sell |
-1,062
| Closed | -$413K | – | 2243 |
|
|
2021
Q2 | $413K | Sell |
1,062
-785
| -43% | -$305K | ﹤0.01% | 1957 |
|
|
2021
Q1 | $663K | Buy |
1,847
+995
| +117% | +$357K | ﹤0.01% | 1729 |
|
|
2020
Q4 | $418K | Buy |
+852
| New | +$418K | ﹤0.01% | 1844 |
|
|
2019
Q4 | – | Sell |
-451
| Closed | -$159K | – | 2115 |
|
|
2019
Q3 | $159K | Buy |
+451
| New | +$159K | ﹤0.01% | 2040 |
|
|
2019
Q2 | – | Sell |
-412
| Closed | -$409K | – | 2064 |
|
|
2019
Q1 | $409K | Sell |
412
-428
| -51% | -$425K | ﹤0.01% | 1866 |
|
|
2018
Q4 | $729K | Sell |
840
-24
| -3% | -$20.8K | ﹤0.01% | 1631 |
|
|
2018
Q3 | $894K | Buy |
864
+97
| +13% | +$100K | ﹤0.01% | 1743 |
|
|
2018
Q2 | $704K | Buy |
767
+473
| +161% | +$434K | ﹤0.01% | 1862 |
|
|
2018
Q1 | $286K | Buy |
+294
| New | +$286K | ﹤0.01% | 2054 |
|